EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanozyme‐Catalyzed Metasurface Plasmon Sensor‐Based Portable Ultrasensitive Optical Quantification Platform for Cancer Biomarker Screening

Rui Li, Hongli Fan, Hanlin Zhou, Youqian Chen, Qingcai Yu, Wenjun Hu, Gang L Liu, Liping Huang iD

Advanced Science · 2023

DOI: 10.1002/advs.202301658 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Rui Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science and Technology, Huazhong University of Science and Technology, 1037 Luo Yu Road, Wuhan, 430074, P. R. China. Hauptthemen laut MEDLINE: Biosensing Techniques, Neoplasms. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Plan of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Developing plasmonic biosensors that are low‐cost, portable, and relatively simple to operate remains challenging. Herein, a novel metasurface plasmon‐etch immunosensor is described, namely a nanozyme‐linked immunosorbent surface plasmon resonance biosensor, for the ultrasensitive and specific detection of cancer biomarkers. Gold‐silver composite nano cup array metasurface plasmon resonance chip and artificial nanozyme‐labeled antibody are used in two‐way sandwich analyte detection. Changes in the biosensor's absorption spectrum are measured before and after chip surface etching, which can be applied to immunoassays without requiring separation or amplification. The device achieved a limit of alpha‐fetoprotein (AFP) detection < 21.74 fM, three orders of magnitude lower than that of commercial enzyme‐linked immunosorbent assay kits. Additionally, carcinoembryonic antigen (CEA) and carbohydrate antigen 125 (CA125) are used for quantitative detection to verify the universality of the platform. More importantly, the accuracy of the platform is verified using 60 clinical samples; compared with the hospital results, the three biomarkers achieve high sensitivity (CEA: 95.7%; CA125: 90.9%; AFP: 86.7%) and specificity (CEA: 97.3%; CA125: 93.9%; AFP: 97.8%). Due to its rapidity, ease of use, and high throughput, the platform has the potential for high‐throughput rapid detection to facilitate cancer screening or early diagnostic testing in biosensing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesNeoplasmsBiomarkers, TumorCarcinoembryonic Antigenalpha-FetoproteinsEarly Detection of CancerImmunoassayCatalysis

Stichwörter der Autor:innen

artificial nanozymecancer biomarkerenzyme-linked immunosorbent assaymetasurface plasmon sensorsurface plasmon resonance biosensor

Substanzen

Biomarkers, TumorCarcinoembryonic Antigenalpha-Fetoproteins

Autor:innen und Institutionen

  • College of Life Science and Technology, Huazhong University of Science and Technology, 1037 Luo Yu Road, Wuhan, 430074, P. R. China.
  • Biosensor R&D Department, Liangzhun (Wuhan) Life Technology Co., Ltd., 666 Gaoxin Avenue, Wuhan, 430070, P. R. China.
  • School of Life and Health Science, Anhui Science and Technology University, Fengyang, 233100, P. R. China.

ORCID-Profile: Liping Huang

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Plan of China
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Li, R., Fan, H., Zhou, H., Chen, Y., Yu, Q., Hu, W., Liu, G. L., & Huang, L. (2023). Nanozyme‐Catalyzed Metasurface Plasmon Sensor‐Based Portable Ultrasensitive Optical Quantification Platform for Cancer Biomarker Screening. Advanced Science. https://doi.org/10.1002/advs.202301658

Vancouver

Li R, Fan H, Zhou H, Chen Y, Yu Q, Hu W, et al. Nanozyme‐Catalyzed Metasurface Plasmon Sensor‐Based Portable Ultrasensitive Optical Quantification Platform for Cancer Biomarker Screening. Advanced Science. 2023. doi:10.1002/advs.202301658

BibTeX
@article{Li2023,
  author = {Li, Rui and Fan, Hongli and Zhou, Hanlin and Chen, Youqian and Yu, Qingcai and Hu, Wenjun and Liu, Gang L and Huang, Liping},
  title = {Nanozyme‐Catalyzed Metasurface Plasmon Sensor‐Based Portable Ultrasensitive Optical Quantification Platform for Cancer Biomarker Screening},
  journal = {Advanced Science},
  year = {2023},
  doi = {10.1002/advs.202301658}
}
Kostenlos starten →